G. Kauffman

发表

The chiral specific synthesis of DMP 754, a platelet GP IIbIIIa antagonist

P. Ma, L. Storace, Zhang Lin-hua, 1996 .

Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).

David S. Millan, Mark T. Kershaw, K. Bair, 2019, Bioorganic & medicinal chemistry letters.

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective and Orally Bioavailable mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors.

Mark T. Kershaw, S. Ashwell, K. Bair, 2019, Journal of medicinal chemistry.

An asymmetric synthesis of (2S,5S)-5-substituted azepane-2-carboxylate derivatives.

K. Farley, D. Wishka, Brian Samas, 2011, The Journal of organic chemistry.

An efficient chiral moderator prepared from inexpensive (+)-3-carene: synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963.

W. A. Nugent, J. Fortunak, P. Confalone, 2000, Organic letters.

Strategy for the enantioselective synthesis of trans-2,4-disubstituted piperidines: application to the CCR3 antagonist IS811.

W. A. Nugent, P. S. Watson, G. Kauffman, 2006, The Journal of organic chemistry.

Rearrangement of Nα-Protected l-Asparagines with Iodosobenzene Diacetate. A Practical Route to β-Amino-l-alanine Derivatives

J. Pesti, Jianguo Yin, G. Kauffman, 1997 .

Synthesis of the methanesulfonates of α‐(4‐chlorophenyl)‐α‐[1‐(2‐chlorophenyl)emenyl]‐1H‐1,2,4‐triazole‐1‐ethanol and α‐[1‐(2‐chlorophenyl)ethenyl]‐α‐(2,4‐difluorophenyl)‐1H‐1,2,4‐triazole‐1‐ethanol, alpha styryl carbinol antifungal agents

Mark D. Lauritsen, R. Olson, W. M. Bryant, 1998 .

NMR spectroscopic investigations of mixed aggregates underlying highly enantioselective 1,2-additions of lithium cyclopropylacetylide to quinazolinones.

W. A. Nugent, D. B. Collum, J. Fortunak, 2001, Journal of the American Chemical Society.

Synthesis and structure based optimization of novel Akt inhibitors.

Tracey Clark, Blaise Lippa, J. Pandit, 2008, Bioorganic & medicinal chemistry letters.

The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.

L. Pustilnik, S. Bhattacharya, J. Chen, 2007, Bioorganic & medicinal chemistry letters.